<DOC>
	<DOCNO>NCT02648932</DOCNO>
	<brief_summary>The study seek compare time formal search hematopoietic cell transplantation ( HCT ) patient 18 year old , randomize haplo-cord search match unrelated donor ( MUD ) search patient acute myeloid leukemia ( AML ) high-risk myelodysplastic syndrome ( MDS )</brief_summary>
	<brief_title>The Rapid Study : Randomized Phase II Study To Expedite Allogeneic Transplant With Immediate Haploidentical Plus Unrelated Cord Donor Search Versus Matched Unrelated Donor Search For AML And High-Risk MDS Patients</brief_title>
	<detailed_description>Primary Objectives To compare time formal search hematopoietic cell transplantation ( HCT ) patient 18 year old , randomize haplo-cord search match unrelated donor ( MUD ) search patient acute myeloid leukemia ( AML ) high-risk myelodysplastic syndrome ( MDS ) Secondary Objectives - To compare percentage patient undergo HCT study cohort - To evaluate overall survival time randomization study cohort</detailed_description>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>Inclusion Criteria Search Phase : 1 . Diagnosis acute myeloid leukemia ( AML ) high highrisk MDS international prognostic scoring system revise transplant recommend 2 . 18 year age old 3 . Subject likely consider allogeneic transplant opinion transplant physician ( base age patient , health , cytogenetics , and/or molecular characteristic ) . 4 . Karnofsky Performance Status ( KPS ) &gt; /= 70 % time enrollment . An exception make low KPS enrollment acute worsen likely resolve treat physician judgment ( e.g. , reversible infection , trauma , medication reaction , etc ) 5 . Ability understand willingness sign write informed consent document Search Phase . 6 . Patient willing consider HCT 7 . A preliminary search identify : 1 . An appropriate minimum 4/6 match umbilical cord unit intermediate resolution HLAA B , high resolution HLADRB cell dose 1 x 10 ( 7 ) TNC/kg single umbilical cord blood ( UCB ) transplant AND 2 . At least one potential 8/8 HLAmatched ( HLAA , B , C , DRB1 ) unrelated donor probability 70 % AND 3 . Availability potential related haploidentical donor . Exclusion Criteria Search Phase : 1 . Prior formal search institute 2 . Diagnosis acute promyelocytic leukemia ( APL ) 3 . Known HLA match related donor without contraindication donate 4 . Life expectancy severely limited concomitant illness uncontrolled infection Inclusion Criteria Transplant Phase 1 . Highrisk AML transplant recommend base cytogenetic , molecular morphologic feature . Patients must meet institutional standard disease control prior transplant . 2 . For MDS . IPSSrevised criterion high high diagnosis . 3 . Subject meet institutional criterion transplant acceptable organ marrow function define : 1 . Serum bilirubin &lt; 2.0mg/dL unless Gilberts disease 2 . Creatinine Clearance &gt; 45 mL/min.1.73m2 estimate modify MDRD equation 3 . Left ventricular function 40 % great 4 . DLCO correct hemoglobin &gt; 50 % 5 . KPS 70 % great 4 . An adequate graft define donor type 1 . Haplocord require haploidentical adult donor 14 year age least 50 kg , cord blood unit least 1.0 x 10 ( 7 ) TNC/kg match least 4/6 intermediate resolution HLAA B high resolution DRB1 . Donor provide standard care consent harvest follow institutional policy . Any donor sample donor research data would obtain separate donor research protocol . 2 . For MUD require 7/8 8/8 HLA match unrelated donor high resolution match HLAA , B , C , DRB1 . DP match DP permissive achieve possible use Tcell epitope strategy . 5 . Written inform consent transplant phase Exclusion Criteria Transplant Phase 1 . Life expectancy severely limited concomitant illness uncontrolled infection 2 . HIVpositive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Acute Myeloid Leukemia ( AML )</keyword>
	<keyword>High-Risk Myelodysplastic Syndrome ( MDS )</keyword>
	<keyword>hematopoietic cell transplantation</keyword>
	<keyword>haplo-cord search</keyword>
	<keyword>match unrelated donor search</keyword>
</DOC>